Metabolomics Reveals that Cysteine Metabolism Plays a Role in Celastrol-Induced Mitochondrial Apoptosis in HL-60 and NB-4 Cells
暂无分享,去创建一个
Xinru Wang | Minjian Chen | Yanhui Hu | Yubang Wang | Xiao-mei Lu | Lei Li | Rongli Sun | Jing Yang | Xiaoling Zhang
[1] M. Voso,et al. Early and sensitive detection of PML-A216V mutation by droplet digital PCR in ATO-resistant acute promyelocytic leukemia , 2019, Leukemia.
[2] Lu Liu,et al. ACTL6A interacts with p53 in acute promyelocytic leukemia cell lines to affect differentiation via the Sox2/Notch1 signaling pathway. , 2019, Cellular signalling.
[3] Yankai Xia,et al. Metabolomics Reveals Metabolic Changes Caused by Low-Dose 4-Tert-Octylphenol in Mice Liver , 2018, International journal of environmental research and public health.
[4] Y. Assaraf,et al. Modulating ROS to overcome multidrug resistance in cancer. , 2018, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.
[5] Yankai Xia,et al. Obesity aggravates toxic effect of BPA on spermatogenesis. , 2017, Environment international.
[6] A. Denicola,et al. N-acetylcysteine improves the quality of red blood cells stored for transfusion. , 2017, Archives of biochemistry and biophysics.
[7] M. Diaz-Meco,et al. Celastrol-Induced Nur77 Interaction with TRAF2 Alleviates Inflammation by Promoting Mitochondrial Ubiquitination and Autophagy. , 2017, Molecular cell.
[8] F. Slack,et al. MUC1-C Inhibition Leads to Decrease in PD-L1 Levels Via up-Regulation of Micro RNAs , 2016 .
[9] J. Chipuk,et al. Physiological and Pharmacological Control of BAK, BAX, and Beyond. , 2016, Trends in cell biology.
[10] C. Croce,et al. Finally, An Apoptosis-Targeting Therapeutic for Cancer. , 2016, Cancer research.
[11] Roy A Jensen,et al. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy. , 2016, Seminars in cancer biology.
[12] M. Haigis,et al. Mitochondria and Cancer , 2016, Cell.
[13] Yankai Xia,et al. Metabolomics profiles delineate uridine deficiency contributes to mitochondria-mediated apoptosis induced by celastrol in human acute promyelocytic leukemia cells , 2016, Oncotarget.
[14] Qun Zhao,et al. Celastrol Induces Cell Apoptosis and Inhibits the Expression of the AML1-ETO/C-KIT Oncoprotein in t(8;21) Leukemia , 2016, Molecules.
[15] K. D. Saha,et al. Heat Killed Attenuated Leishmania Induces Apoptosis of HepG2 Cells Through ROS Mediated p53 Dependent Mitochondrial Pathway , 2016, Cellular Physiology and Biochemistry.
[16] A. Coulibaly,et al. Targeting acute myeloid leukemia with a small molecule inhibitor of the Myb/p300 interaction. , 2016, Blood.
[17] S. Tait,et al. Mitochondria and the hallmarks of cancer , 2016, The FEBS journal.
[18] D. Green,et al. Cell Death Signaling. , 2015, Cold Spring Harbor perspectives in biology.
[19] T. Horvath,et al. Mitochondrial ROS Signaling in Organismal Homeostasis , 2015, Cell.
[20] M. Nassiri,et al. Acute Promyelocytic Leukemia: A Review and Discussion of Variant Translocations. , 2015, Archives of pathology & laboratory medicine.
[21] M. Dai,et al. Celastrol induces apoptosis of human osteosarcoma cells via the mitochondrial apoptotic pathway , 2015, Oncology reports.
[22] Ralph Mazitschek,et al. Treatment of Obesity with Celastrol , 2015, Cell.
[23] Jiong Hu,et al. Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide , 2015, EBioMedicine.
[24] S. Fulda. Targeting apoptosis for anticancer therapy. , 2015, Seminars in cancer biology.
[25] Zhaoming Ye,et al. Celastrol induces apoptosis and autophagy via the ROS/JNK signaling pathway in human osteosarcoma cells: an in vitro and in vivo study , 2015, Cell Death and Disease.
[26] Seamus J. Martin,et al. Parkin sensitizes toward apoptosis induced by mitochondrial depolarization through promoting degradation of Mcl-1. , 2014, Cell reports.
[27] Limin Li,et al. Arsenic trioxide and mannitol for the treatment of acute promyelocytic leukemia relapse in the central nervous system. , 2014, Blood.
[28] Jiang Li,et al. Targeting Apoptosis Pathways in Cancer and Perspectives with Natural Compounds from Mother Nature , 2014, Cancer Prevention Research.
[29] Hui Zhou,et al. Inhibition of miR-17 and miR-20a by oridonin triggers apoptosis and reverses chemoresistance by derepressing BIM-S. , 2014, Cancer research.
[30] G. Uzan,et al. Celastrol Inhibits Lung Infiltration in Differential Syndrome Animal Models by Reducing TNF-α and ICAM-1 Levels while Preserving Differentiation in ATRA-Induced Acute Promyelocytic Leukemia Cells , 2014, PloS one.
[31] R. Gabdoulline,et al. ROS-dependent activation of JNK converts p53 into an efficient inhibitor of oncogenes leading to robust apoptosis , 2014, Cell Death and Differentiation.
[32] Fatima Al-Shahrour,et al. Niche-based screening identifies small-molecule inhibitors of leukemia stem cells. , 2013, Nature chemical biology.
[33] D. Newmeyer,et al. The rheostat in the membrane: BCL-2 family proteins and apoptosis , 2013, Cell Death and Differentiation.
[34] A. Jemal,et al. Outcome of older patients with acute myeloid leukemia , 2013, Cancer.
[35] A. Gross,et al. A ROS rheostat for cell fate regulation. , 2013, Trends in cell biology.
[36] J. Hyun,et al. The critical role of catalase in prooxidant and antioxidant function of p53 , 2012, Cell Death and Differentiation.
[37] G. Avvisati. Coagulopathy in APL: a step forward? , 2012, Blood.
[38] S. Grant,et al. Inhibition of Bcl-2 antiapoptotic members by obatoclax potently enhances sorafenib-induced apoptosis in human myeloid leukemia cells through a Bim-dependent process. , 2012, Blood.
[39] X. Cui. Reactive oxygen species: the achilles' heel of cancer cells? , 2012, Antioxidants & redox signaling.
[40] Huanjie Shao,et al. PU.1 can regulate the ZNF300 promoter in APL-derived promyelocytes HL-60. , 2010, Leukemia research.
[41] M. Surette,et al. Cysteine biosynthesis, oxidative stress and antibiotic resistance in Salmonella typhimurium. , 2010, Research in microbiology.
[42] Evan W. Miller,et al. An Integrated Imaging Approach to the Study of Oxidative Stress Generation by Mitochondrial Dysfunction in Living Cells , 2010, Environmental health perspectives.
[43] H. Dombret,et al. Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. , 2009, Blood.
[44] H. Koeffler,et al. Blockade of mTOR signaling potentiates the ability of histone deacetylase inhibitor to induce growth arrest and differentiation of acute myelogenous leukemia cells , 2008, Leukemia.
[45] I. Wilson,et al. Evaluation of the repeatability of ultra-performance liquid chromatography-TOF-MS for global metabolic profiling of human urine samples. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.
[46] Monica L Guzman,et al. Discovery of agents that eradicate leukemia stem cells using an in silico screen of public gene expression data. , 2008, Blood.
[47] Di Chen,et al. Celastrol, a triterpene extracted from the Chinese "Thunder of God Vine," is a potent proteasome inhibitor and suppresses human prostate cancer growth in nude mice. , 2006, Cancer research.
[48] W. Ludwig,et al. Stress-induced activation of the p53 tumor suppressor in leukemia cells and normal lymphocytes requires mitochondrial activity and reactive oxygen species. , 2005, Blood.
[49] P. Dekhuijzen. Antioxidant properties of N‐acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease , 2004, European Respiratory Journal.
[50] N. Sakato,et al. Apoptosis Induction in HL-60 Cells and Inhibition of Topoisomerase II by Triterpene Celastrol , 2003, Bioscience, biotechnology, and biochemistry.
[51] Ki-Hwan Lee,et al. Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. , 2002, Biochemical and biophysical research communications.
[52] Xin Lu,et al. Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.
[53] T. Fan,et al. Bcl-2 family proteins and apoptosis. , 2002, Sheng wu hua xue yu sheng wu wu li xue bao Acta biochimica et biophysica Sinica.
[54] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[55] K. Robertson,et al. Retinoic acid-resistant HL-60R cells harbor a point mutation in the retinoic acid receptor ligand-binding domain that confers dominant negative activity. , 1992, Blood.
[56] S. Collins,et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia , 1979 .
[57] V. Costa,et al. The Multifaceted Role of Annexin A1 in Viral Infections , 2023, Cells.
[58] Ma Bao-gen. Effects of tripterine on proliferation and apoptosis of acute myeloid leukemia primary cells , 2011 .
[59] N. Turner,et al. (cid:1) 2 (VIII) Collagen Substrata Enhance Endothelial Cell Retention Under Acute Shear Stress Flow via an (cid:1) 2 (cid:2) 1 Integrin–Dependent Mechanism An In Vitro and In Vivo Study , 2006 .
[60] S. Collins,et al. Characterization of the continuous, differentiating myeloid cell line (HL-60) from a patient with acute promyelocytic leukemia. , 1979, Blood.